Chemistry: analytical and immunological testing – Biospecific ligand binding assay
Patent
1995-02-03
1998-05-19
Jones, W. Gary
Chemistry: analytical and immunological testing
Biospecific ligand binding assay
435 6, 435 71, 435 72, 435 78, 5303501, G01N 33566, C12Q 168, C01N 3353
Patent
active
057535167
ABSTRACT:
This invention relates primarily to opioid binding proteins specifically, the invention relates to lymphocyte-specific opioid recognition sites and methods and compositions related to them. For example, methods of determining agonists and antagonists of immune cell-specific opioid binding protein are presented.
REFERENCES:
Heagy et al, "Opioid receptor agonists and Ca modulation in human B cell lines", J. Immunol. 149:4074-4081, Dec. 1992.
Sharp et al, "Expression of opiod receptor by immune cells", J. Neuroimmunol. 69:3-13, 1996.
Marullo et al, "Human B2 adrenergic receptors expressed in Escherichia coil membranes retain their pharmacologica properties", Proc. Natl. Acad. Sci. 85:7551-7555, Oct. 1988.
Bidlack et al, "K-opioid binding sites on a murine lymphoma cell line", Eur. J. Pharm. 227:257-265, 1992.
Schweickart et al, "Cloning of human and mouse EBI1, a lymphoid specific g-protein coupled receptor encoded on human chromosome 17q12-a21.2", Genomics 23:643-650, 1994.
Payette et al, "Expression and pharmacological characterization of the human M1 muscarinic receptor in Sacchromyces cerevisiae", FEBS Lett. 266:21-25, Jun. 1990.
House et al, "In vitro evaluation of fentanyl and meperidine for immunomodulatory activity", Immunol. Lett. 46:117-124, 1995.
Bergelson et al., "Identification of the Integrin VLA-2 as a Receptor for Echovirus 1," Science, 255:1718-1720, 1992.
Birkenbach et al., "Epstein-Barr Virus-Induced Genes: First Lymphocyte-Specific G Protein Coupled Peptide Receptors," J. Virol., 67(4):2209-2220, 1993.
Borboni et al., ".beta.-Endorphin Receptors on Cultured and Freshly Isolated Lymphocytes from Normal Subjects," Biochem. biophys. Res. Commun., 163(1):642-648, 1989.
Bradbury et al., "The CD19 Signal Transduction Complex of B Lymphocytes: Deletion of the CD19 Cytoplasmic Domain Alters Signal Transduction but Not Complex Formation with TAPA-1 and Leu 13," J. Immunol., 151(6):2915-2927, 1993.
Bryant et al., "Morphine-Induced Immunomodulation is Not Related to Serum Morphine Concentrations," E.J. Pharmacol., 149:165-169, 1988.
Carlson et al., "Thrombin and Phorbol Esters Cause the Selective Phosphorylation of a G Protein Other Than G.sub.i in Human Platelets," J. Biol. Chem., 264(22):13298-13305, 1989.
Carr et al., "Evidence for .kappa.-Class Opioid Receptor on Cells of the Immune System," Cell. Immunol., 116:44-51, 1988.
Chang et al., "Dissection of the Human CD2 Intracellular Domain," J. Exp. Med., 169:2073-2083, 1989.
Chang et al., "Interaction of Enkephalin with Opiate Receptors in Intact Cultured Cells," Mol. Pharmoc., 14:961-970, 1978.
Chao et al., "Lethality of Morphine in Mice Infected with Toxoplasma gondii," J. Pharmacol. Exp. Ther., 252(2):605-609, 1990.
Chen et al., "Molecular Cloning and Functional Expression of a .mu.-Opioid Receptor from Rat Brain," Mol. Pharm., 44:8-12, 1993.
Chen et al., "Molecular Cloning of a Rat .kappa. Opioid Receptor Reveals Sequence Similarities to the .mu. and .delta. Opioid Receptors,"Biochem J., 295:625-628, 1993.
Chen et al., "Molecular Cloning, Tissue Distribution and Chromosomal Localization of a Novel Member of the Opioid Receptor Gene Family," FEBS Lett., 347:279-283, 1994.
Chen and Yu, "Differential Regulation by cAMP-dependent Protein Kinase and Protein Kinase C of the .mu. Opioid Receptor Coupling to a G Protein-activated K.sup.+ Channel," J. Biol. Chem., 269(11):7839-7842, 1994.
Corbett et al., "Selectivities of Opioid Peptide Analogues as Agonists and Antagonists at the .kappa.-Receptor," Br. J. Pharmacol., 83:271-279, 1984.
Dohlman, H.G., "Model Systems for the Study of Seven-Transmembrane-Segment Receptors,"Annu. Rev. Biochem., 60:653-688, 1991.
Dohlman et al., "A Family of Receptors Coupled to Guanine Nucleotide Regulatory Proteins," Biochemistry, 26(10):2657-2664, 1987.
Evans et al., "Cloning of a Delta Opioid Receptor by Functional Expression," Science, 258:1952-1955, 1992.
Foris et al., "Concentration-Dependent Effect of Met-Enkephalin on Human Polymorphonuclear Leukocytes," Ann. N.Y. Acad. Sci., 496:151-157, 1987.
Forsyth, K.D., "Anti-CD9 Antibodies Augment Neutrophil Adherence to Endothelium," Immunol., 72:292-296, 1991.
Frielle et al., "Structural Basis of .beta.-adrenergic Receptor Subtype Specificity Studied with Chimeric .beta.1/.beta.2-adrenergic Receptors," Proc. Natl. Acad. Sci. USA, 85:9494-9498, 1988.
Fujioka et al., "Purification and Reconstitution of .mu.-opioid Receptors in Liposome" J. Chromat., 597:429-433, 1992.
Fukuda et al., "Primary Structures and Expression from cDNAs of Rat Opioid Receptor .kappa.-and .mu.-subtypes," FEBS Lett., 327(3)311-314, 1993.
Gilmore et al., "The Role of Opioid Peptides in Immunomodulation," Ann. N.Y. Acad. Sci., 597:252-263, 1990.
Gioannini et al., "Evidence for the Presence of Disulfide Bridges in Opioid Receptors Essential for Ligand Binding. Possible Role in Receptor Activation," J. Mol. Recogn., 2(1):44-48, 1989.
Heagy et al., "Opioid Receptor Agonists and Ca2.sup.+ Modulation in Human B Cell Lines," J. Immunol., 149(12):4072-4081, 1992.
Heagy et al., "Neurohormones Regulate T Cell Function," J. Exp. Med., 171:1625-1633, 1990.
Kieffer et al.,"The .delta.-opioid Receptor: Isolation of a cDNA by Expression Cloning and Pharmacological Characterization," Proc. Natl. Acad. Sci. USA, 89:12048-12052, 1992.
Kong et al., "A Single Residue, Aspartic Acid 95, in the .delta. Opioid Receptor Specifies Selective High Affinity Agonist Binding," J. Biol. Chem., 268(31):23055-23058, 1993.
Lane et al., "Regulation of an Opioid-binding Protein in NG108-15 Cells Parallels Regulation of .delta.-opioid Receptors," Proc. Natl. Acad. Sci. USA, 89:11234-11238, 1992.
Li et al., "Cloning of a Cellular Factor, Interleukin Binding Factor, That Binds to NFAT-like Motifs in the Human Immunodeficiency Virus Long Terminal Repeat,"Proc. Natl. Acad. Sci. USA, 88:7739-7743, 1991.
Li et al., "Purification of Opioid Receptor in the Presence of Sodium Ions," Life Sciences, 51(15):1177-1185, 1992.
Lippman et al., "Opioid-binding Cell Adhesion Molecule (OBCAM)-related Clones from a Rat Brain cDNA Library," Gene, 117:249-254, 1992.
Loh et al., "Molecular Characterization of Opioid Receptors," Annu. Rev. Pharmacol. Toxicol., 30:123-147, 1990.
Lu et al., "The Effects of Agranulocytic and Nonagranulocytic Drugs in Rabbits Concurrently Treated with Busulfan (Myleran) III. Thiouracil, Morphine, and Penicillin," Toxicology and Applied Pharmacology, 2:171-182, 1960.
Lutz et al., "Opioid Receptors and Their Pharmacological Profiles," J. Receptor Research, 12(3):267-286, 1992.
Madden et al., "Binding of Naloxone to Human T-Lymphocytes," Biochem. Pharmacol., 36(23):4103-4109, 1987.
Maneckjee et al., "Nonconventional Opioid Binding Sites Mediate Growth Inhibitory Effects of Methadone on Human Lung Cancer Cells," Proc. Natl. Acad. Sci. USA, 89:1169-1173, 1992.
Maneckjee et al., "Characterization of a Polyclonal Antibody to the .mu. Opioid Receptor," Journal of Neuroimmunology, 17:199-208, 1988.
Mansour et al., "Anatomy of CNS Opioid Receptors," Trends in Neurosci., 7:2445-2453, 1987.
Manzanares et al., "Kappa-Opioid-Receptor-Mediated Regulation of .alpha.-Melanocyte-Stimulating Hormone Secretion and Tuberohypophysial Dopaminergic Neuronal Activity," Neuroendocrinology, 52:200-205, 1990.
Mierendorf et al., "Gene Isolation by Screening .lambda.gt11 Libraries with Antibodies," Methods in Enzymology, 152:458-469, 1987.
Mitamura et al., "The 27-kD Diphtheria Toxin Receptor-Associated Protein (DRAP27) from Vero Cells is the Monkey Homologue of Haman CD9 Antigen: Expression of DRAP27 Elevates the Number of Diphtheria Toxin Receptors on Toxin-Sensitive Cells," J. Cell. Biol., 118(6):1389-1399, 1992.
Miyake et al., "Identification of the Motility-Related Protein (MRP-1), Recognized by Monoclonal Antibody M31-15, Which Inhibits Cells Motility," J. Exp. Med., 174:1347-1354, 1991.
Moore, T.C., "Modification of Lymphocyte Traffic by Vasoactive Neurotransmitter Substances," Immunol., 52:511-518, 1984.
Nakajima et al., "Direct Linkage of Three Tachykinin Receptors to Stimulation of Both Phosphatidylinositol Hydrolysis and
Finberg Robert W.
Heagy Wyrta E.
Fredman Jeffrey
Jones W. Gary
LandOfFree
Screening method for ligands of the EBI-1 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Screening method for ligands of the EBI-1 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening method for ligands of the EBI-1 receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1852320